Literature DB >> 3793866

Effect of repeated in vitro transfer of Pasteurella haemolytica A1 on encapsulation, leukotoxin production, and virulence.

M J Gentry, A W Confer, R C Craven.   

Abstract

Pasteurella haemolytica serotype 1 was transferred daily for 128 serial passages on both unsupplemented brain heart infusion agar and the same basal medium supplemented with bovine blood, horse serum, and yeast extract. Repeatedly transferred cultures were shown to retain the ability to produce both capsular material and leukotoxin. Furthermore, intact organisms were found to be as toxic in vitro for bovine leukocytes and as virulent for mice as unpassaged cultures. These results indicate that the precaution of using only freshly isolated cultures in the study of this organism may not be necessary.

Entities:  

Mesh:

Substances:

Year:  1987        PMID: 3793866      PMCID: PMC265842          DOI: 10.1128/jcm.25.1.142-145.1987

Source DB:  PubMed          Journal:  J Clin Microbiol        ISSN: 0095-1137            Impact factor:   5.948


  21 in total

1.  Experimental infections of Pasteurella haemolytica in mice and their use in demonstrating passive immunity.

Authors:  G R SMITH
Journal:  J Comp Pathol       Date:  1958-10       Impact factor: 1.311

2.  Colonial variation of Pasteurella haemolytica isolated from sheep.

Authors:  E L BIBERSTEIN; M E MEYER; P C KENNEDY
Journal:  J Bacteriol       Date:  1958-10       Impact factor: 3.490

3.  Studies on Pasteurella multocida. II. Identification of antigenic characteristics and colonial variants.

Authors:  G R CARTER
Journal:  Am J Vet Res       Date:  1957-01       Impact factor: 1.156

Review 4.  The chemistry and biosynthesis of selected bacterial capsular polymers.

Authors:  F A Troy
Journal:  Annu Rev Microbiol       Date:  1979       Impact factor: 15.500

5.  The role of capsular and somatic antigens in immunization of mice against Pasteurella hemolytica infection.

Authors:  H D Knight; E L Biberstein; M Allison
Journal:  Cornell Vet       Date:  1969-01

6.  Rapid plate agglutination procedure for serotyping Pasteurella haemolytica.

Authors:  G H Frank; G E Wessman
Journal:  J Clin Microbiol       Date:  1978-02       Impact factor: 5.948

7.  Evidence of cytocidal effects of Pasteurella haemolytica on bovine peripheral blood mononuclear leukocytes.

Authors:  K L Kaehler; R J Markam; C C Muscoplat; D W Johnson
Journal:  Am J Vet Res       Date:  1980-10       Impact factor: 1.156

8.  Interaction between Pasteurella haemolytica and bovine alveolar macrophages: cytotoxic effect on macrophages and impaired phagocytosis.

Authors:  R J Markham; B N Wilkie
Journal:  Am J Vet Res       Date:  1980-01       Impact factor: 1.156

9.  INTERRELATIONSHIPS OF SMOOTH AND NONSMOOTH VARIANTS IN THE DISSOCIATION OF PASTEURELLA HAEMOLYTICA.

Authors:  G E WESSMAN
Journal:  J Bacteriol       Date:  1964-08       Impact factor: 3.490

10.  The bovine alveolar macrophage. II. In vitro studies with Pasteurella haemolytica.

Authors:  M L Benson; R G Thomson; V E Valli
Journal:  Can J Comp Med       Date:  1978-07
View more
  4 in total

1.  Molecular analysis of the leukotoxin determinants from Pasteurella haemolytica serotypes 1 to 16.

Authors:  L L Burrows; E Olah-Winfield; R Y Lo
Journal:  Infect Immun       Date:  1993-12       Impact factor: 3.441

2.  Biochemical conditions for the production of polysialic acid by Pasteurella haemolytica A2.

Authors:  L Puente-Polledo; A Reglero; C González-Clemente; L B Rodríguez-Aparicio; M A Ferrero
Journal:  Glycoconj J       Date:  1998-09       Impact factor: 2.916

3.  Extracellular neuraminidase production by Pasteurella species isolated from infected animals.

Authors:  D C Straus; C W Purdy
Journal:  Curr Microbiol       Date:  1995-11       Impact factor: 2.188

4.  Granulocyte plasma membrane damage by leukotoxic supernatant from Pasteurella haemolytica A1 and protection by immune serum.

Authors:  B Styrt; R D Walker; J C White; L D Dahl; J C Baker
Journal:  Can J Vet Res       Date:  1990-01       Impact factor: 1.310

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.